Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer

被引：1
|
作者：
Atkins, CD
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1998年 / 90卷 / 06期
关键词：
D O I：
10.1093/jnci/90.6.468
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：468 / 468
页数：1
相关论文
共 50 条
  • [1] Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer
    Fisher, B
    Dignam, J
    Wolmark, N
    DeCillis, A
    Emir, B
    Wickerham, DL
    Bryant, J
    Dimitrov, NV
    Abramson, N
    Atkins, JN
    Shibata, H
    Deschenes, L
    Margolese, RG
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (22): : 1673 - 1682
  • [2] Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer - Response
    Dignam, J
    Fisher, B
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (06): : 468 - 469
  • [3] Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer
    Hassett, Michael J.
    Hughes, Melissa E.
    Niland, Joyce C.
    Edge, Stephen B.
    Theriault, Richard L.
    Wong, Yu-Ning
    Wilson, John
    Carter, W. Bradford
    Blayney, Douglas W.
    Weeks, Jane C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) : 5553 - 5560
  • [4] Effect of tamoxifen after chemotherapy in hormone receptor-positive, node-negative breast cancer
    Panasci, LC
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2392 - 2392
  • [5] Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
    Paik, Soonmyung
    Tang, Gong
    Shak, Steven
    Kim, Chungyeul
    Baker, Joffre
    Kim, Wanseop
    Cronin, Maureen
    Baehner, Frederick L.
    Watson, Drew
    Bryant, John
    Costantino, Joseph P.
    Geyer, Charles E., Jr.
    Wickerham, D. Lawrence
    Wolmark, Norman
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (23) : 3726 - 3734
  • [6] Chemotherapy use for hormone receptor-positive, node-negative breast cancer
    Hassett, M. J.
    Hughes, M. E.
    Niland, J. C.
    Edge, S. B.
    Theriault, R. L.
    Wong, Y.
    Wilson, J.
    Carter, B. W.
    Blayney, D. W.
    Weeks, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
    Foekens, John A.
    Sieuwerts, Anieta M.
    Smid, Marcel
    Look, Maxime P.
    de Weerd, Vanja
    Boersma, Antonius W. M.
    Klijn, Jan G. M.
    Wiemer, Erik A. C.
    Martens, John W. M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) : 13021 - 13026
  • [8] 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
    Gulisa Turashvili
    Joanne F. Chou
    Edi Brogi
    Monica Morrow
    Maura Dickler
    Larry Norton
    Clifford Hudis
    Hannah Y. Wen
    Breast Cancer Research and Treatment, 2017, 166 : 69 - 76
  • [9] The financial burden of using Oncotype Dx for patients with lymph node-negative and estrogen receptor-positive breast cancer in Australia
    Sakata, Shinichiro
    Cronk, Michelle
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (01) : 94 - 95
  • [10] 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
    Turashvili, Gulisa
    Chou, Joanne F.
    Brogi, Edi
    Morrow, Monica
    Dickler, Maura
    Norton, Larry
    Hudis, Clifford
    Wen, Hannah Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 69 - 76
12345